Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression
2019 ◽
Vol 43
(4)
◽
pp. 436-445
◽
2018 ◽
Vol 498
(3)
◽
pp. 551-558
◽
2017 ◽
Vol 25
(1)
◽
pp. 1-9
◽
2016 ◽
Vol 6
(8)
◽
pp. 649-658